Additional costs: According to a study[11] published in the international journal Lung Cancer, the failure of initial treatment is associated with markedly increased costs. Patients needing additional rounds of treatment had total costs of$120,650,compared to$45,953for those receiving initial treatmen...
O-10 Economic burden of lung cancer in the US: Costs by treatment course and costs of failed treatmentdoi:10.1016/S0169-5002(03)91668-0LucieKutikovaandLeeBowmanandStellaChangandStaceySDOSLung Cancer
-liability costs for clinical phases of lung cancer care (pre-diagnosis,staging, initial, continuing, and terminal), stratified by treatment, stage, and non- vs. small celllung cancer. Lung cancer-attributable costs were estimated by subtracting each patient's own pre-diagnosis costs. Costs were...
In patients with SCLC, the costs of diagnosis and terminal care each represented 41% of the total cost.Conclusion: The cost of treatment of recurrence of lung carcinoma is high, and is related to the number of lines of chemotherapy and the use of radiotherapy and surgery. 展开 ...
Treatment, overall survival, and costs in patients with ALK-positive non-small-cell lung cancer after crizotinib monotherapy BACKGROUND: Limited post-crizotinib treatment options for ALK-positive non-small cell lung cancer (NSCLC) might lead to poor survival and high economic bur... A Guérin,M ...
摘要: BackgroundWe studied trends in lung cancer treatment cost over time by phase of care, treatment strategy, age, stage at diagnosis, and histology.关键词:healthcare costs lung cancer phase of care SEER‐Medicare treatment DOI: 10.1002/cam4.1896 年份: 2018 ...
Second-line treatment options for patients with relapsed, extensive-stage small cell lung cancer (ES-SCLC) are limited, and even with currently available t
Costs vary depending on the type of cancer treatment. Here is a breakdown comparison chart to show some popular cancer treatments and their costs in different countries. Cost Comparison for Cancer Treatment Cancer TreatmentCountryCost ChemotherapyIndia$4000 - $5000 ...
Clinical pathways were originally created to standardize cancer care and ensure patients receive the best evidence-based treatment for their disease. A divide has developed, however, between pathways that primarily serve physicians and those that cater to payers that are trying to rein in cost...
However, the estimates are at lower side owing to low screening (only 0.9% of women were ever screened) for breast cancer [2]. The breast cancer treatment is also very limited in the country, largely located in city centres and expensive. On the other hand, the health spending in the ...